Please assess the completion status of the following clinical trial:

Trial Title: Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Children ages 7 to \<19~* Acute vaso-occlusive crisis~* Persistent pain despite initial pain management with intravenous (IV) opioids~Exclusion Criteria:~* Contraindications to the use of ketamine~* Mental retardation or psychological conditions that may affect the proper evaluation of pain and side effects~* Known allergy to ketamine

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Patients receiving ketamine are those patients, arm 1, that are sill experiencing pain after Morphine has been given.

Based on this trial design, predict the completion outcome and termination type (if applicable).